XDGE:XETRA:XETRA-db x-trackers USD Corporate Bond UCITS DR 2D Hedged (EUR)

ETF | Others |

Last Closing

USD 11.0725

Change

+0.04 (+0.33)%

Market Cap

USD 0.14B

Volume

2.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing XDGE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.23% 13% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.23% 13% F 20% F
Trailing 12 Months  
Capital Gain 10.06% 33% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.06% 32% F 37% F
Trailing 5 Years  
Capital Gain -25.02% 4% F 12% F
Dividend Return 9.30% 83% B 51% F
Total Return -15.72% 7% C- 14% F
Average Annual (5 Year Horizon)  
Capital Gain -7.56% N/A N/A 9% A-
Dividend Return -5.12% N/A N/A 11% F
Total Return 2.44% N/A N/A 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 7.22% N/A N/A 78% C+
Risk Adjusted Return -70.92% N/A N/A 7% C-
Market Capitalization 0.14B 39% F 35% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.